Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Humanized TNFΞ± monoclonal antibody
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Rheumatoid Arthritis
1 trial -
Hutrukin
XBiotech Germany GmbH
Pharmacokinetics
1 trial -
Hydrocodone Bitartrate extended-release tablet
Teva Pharma GmbH
Renal Impairment
1 trial -
Hydrocodone bitartrate extended-release tablet
Teva Pharma GmbH
Hepatic Impairment
1 trial -
INC280 single agent
Novartis Pharmaceuticals
Non-Small Cell Lung Cancer
1 trial -
INO-1400
INOVIO PHARMACEUTICALS, INC.
Breast Cancer
1 trial -
INO-1800
INOVIO PHARMACEUTICALS, INC.
Hepatitis B
1 trial -
INO-3106, INO-9012
INOVIO PHARMACEUTICALS, INC.
Aerodigestive Precancerous Lesions and Malignancies
1 trial -
INO-3401 + EP
INOVIO PHARMACEUTICALS, INC.
Healthy
1 trial -
INO-3605
INOVIO PHARMACEUTICALS, INC.
Healthy
1 trial -
INO-4201
INOVIO PHARMACEUTICALS, INC.
Ebola Virus Disease
1 trial -
INO-4201
INOVIO PHARMACEUTICALS, INC.
Ebola Vaccine
1 trial -
INO-4500
INOVIO PHARMACEUTICALS, INC.
Lassa Fever
2 trials -
INO-5401
INOVIO PHARMACEUTICALS, INC.
BRCA1/2 Mutation
1 trial -
INO-A002
INOVIO PHARMACEUTICALS, INC.
Healthy Volunteers
1 trial -
INZ-701, INZ-701
Lacuna Pharma Pty Ltd
Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency or ATP-binding Cassette Sub-family C Member 6 (ABCC6) Deficiency
1 trial -
ION251
IONIS PHARMACEUTICALS INC
Relapsed Multiple Myeloma
1 trial -
ION269
IONIS PHARMACEUTICALS INC
Alzheimer Disease
1 trial -
ION356
IONIS PHARMACEUTICALS INC
Pelizaeus-Merzbacher Disease
1 trial -
ION464
IONIS PHARMACEUTICALS INC
Multiple System Atrophy
1 trial -
ION537
IONIS PHARMACEUTICALS INC
Advanced Solid Tumors
1 trial -
ION547
IONIS PHARMACEUTICALS INC
Healthy Volunteers
1 trial -
ION904
IONIS PHARMACEUTICALS INC
Healthy Volunteers
1 trial -
IONIS ANGPTL3-LRx
IONIS PHARMACEUTICALS INC
Hypertriglyceridemia
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources